Bank of New York Mellon’s Larimar Therapeutics LRMR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $359K | Buy |
|
|||||
|
2025
Q2 | $289K | Sell |
|
|||||
|
2025
Q1 | $216K | Hold |
|
|||||
|
2024
Q4 | $389K | Buy |
|
|||||
|
2024
Q3 | $646K | Sell |
|
|||||
|
2024
Q2 | $978K | Buy |
|
|||||
|
2024
Q1 | $651K | Sell |
|
|||||
|
2023
Q4 | $440K | Sell |
|
|||||
|
2023
Q3 | $386K | Hold |
|
|||||
|
2023
Q2 | $306K | Buy |
|
|||||
|
2023
Q1 | $131K | Hold |
|
|||||
|
2022
Q4 | $119K | Buy |
|
|||||
|
2022
Q3 | $60K | Hold |
|
|||||
|
2022
Q2 | $37K | Hold |
|
|||||
|
2022
Q1 | $77K | Hold |
|
|||||
|
2021
Q4 | $205K | Hold |
|
|||||
|
2021
Q3 | $219K | Hold |
|
|||||
|
2021
Q2 | $187K | Hold |
|
|||||
|
2021
Q1 | $277K | Buy |
|
|||||
|
2019
Q4 | – | Sell |
|
|||||
|
2019
Q3 | $19K | Hold |
|
|||||
|
2019
Q2 | $30K | Sell |
|
|||||
|
2019
Q1 | $288K | Sell |
|
|||||
|
2018
Q4 | $800K | Buy |
|
|||||
|
2018
Q3 | $1.83M | Buy |
|
|||||
|
2018
Q2 | $1.31M | Buy |
|
|||||
|
2018
Q1 | $656K | Buy |
|
|||||
|
2017
Q4 | $405K | Buy |
|
|||||
|
2017
Q3 | $129K | Buy |
|
|||||
|
2017
Q2 | $126K | Sell |
|
|||||
|
2017
Q1 | $485K | Buy |
|
|||||
|
2016
Q4 | $313K | Buy |
|
|||||
|
2016
Q3 | $230K | Sell |
|
|||||
|
2016
Q2 | $515K | Sell |
|
|||||
|
2016
Q1 | $627K | Buy |
|
|||||
|
2015
Q4 | $473K | Sell |
|
|||||
|
2015
Q3 | $2.4M | Sell |
|
|||||
|
2015
Q2 | $2.87M | Buy |
|
|||||
|
2015
Q1 | $1.95M | Buy |
|
|||||
|
2014
Q4 | $947K | Buy |
|
|||||
|
2014
Q3 | $320K | Buy |
|